Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2017

Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers

Résumé

Aptamers are nucleic acids referred to as chemical antibodies as they bind to their specific targets with high affinity and selectivity. They are selected via an iterative process known as ‘selective evolution of ligands by exponential enrichment’ (SELEX). Aptamers have been developed against numerous cancer targets and among them, many tumor cell-membrane protein biomarkers. The identification of aptamers targeting cell-surface proteins has mainly been performed by two different strategies: protein- and cell-based SELEX, when the targets used for selection were proteins and cells, respectively. This review aims to update the literature on aptamers targeting tumor cell surface protein biomarkers, highlighting potentials, pitfalls of protein- and cell-based selection processes and applications of such selected molecules. Aptamers as promising agents for diagnosis and therapeutic approaches in oncology are documented, as well as aptamers in clinical development.

Domaines

Cancer
Fichier principal
Vignette du fichier
9768ca7903e2a69b358f44e1e3a5dadb731b.pdf (960.63 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03520039 , version 1 (05-12-2023)

Identifiants

Citer

Marie-Cécile Mercier, Monique Dontenwill, Laurence Choulier. Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers. Cancers, 2017, 9 (6), pp.69. ⟨10.3390/cancers9060069⟩. ⟨hal-03520039⟩

Collections

CNRS SITE-ALSACE
13 Consultations
11 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More